Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.
Autor(es): Souayah Nizar; Nasar Abu.; Suri M. Fareed K.; Qureshi Adnan I.
Resumo: Using the data from Vaccine Adverse Event Reporting System, we present 54 reports of Guillain-Barre Syndrome (GBS) after vaccination that occurred in United States in 2004. In 38 of the patients, GBS occurred within 6 weeks. The highest number (n=31) of GBS was observed in patients receiving influenza vaccine followed by hepatitis vaccine (n=9), 1 patient died and 10 patients were disabled following the event. We conclude that vaccines other than influenza vaccine can be associated with GBS.
Imprenta: Vaccine, v. 25, n. 29, p. 5253-5235, 2007
Identificador do objeto digital: 10.1016/j.vaccine.2007.03.053
Descritores: Guillain-Barre Syndrome - Vaccine ; Guillain-Barre Syndrome - Epidemiology ; Guillain-Barre Syndrome - Public health
Data de publicação: 2007
